Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology Read more
FDA accepts application for Roche’s Vabysmo for the treatment of retinal vein occlusion (RVO) Read more
AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN’S DISEASE Read more
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next Generation Sequencing-Based Testing for Cancer Patients in International Markets Read more
Roche launches Institute of Human Biology to accelerate breakthroughs in R&D by unlocking the potential of human model systems Read more
FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults Read more
Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy Read more
FDA Approves Genentech’s Polivy in Combination With R-CHP for People With Certain Types of Previously Untreated Diffuse Large B-cell Lymphoma Read more
AbbVie Announces European Commission Approval of RINVOQ (upadacitinib) for the Treatment of Moderately to Severely Active Crohn’s Disease Read more
BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION Read more